Literature DB >> 11906615

Prognosis of a large cohort of patients with hepatocellular carcinoma in a single European centre.

Christoph Herold1, Thomas Reck, Peter Fischler, Rudolf Ott, Martin Radespiel-Troeger, Marion Ganslmayer, Werner Hohenberger, Eckhart G Hahn, Detlef Schuppan.   

Abstract

BACKGROUND/AIM: Only a few follow up data are available for patients with hepatocellular carcinoma (HCC) in Europe and the USA. Therefore, we analysed all HCC patients admitted to our hospital between 1988 and 1999.
METHODS: We documented aetiology, stage (HCC: Okuda and UICC classifications, liver cirrhosis: Child-Pugh score), and diagnostic and therapeutic measures of 281 consecutive HCC patients. Survival time was calculated as a function of staging and therapy.
RESULTS: Cirrhosis was diagnosed in all patients. Seventy-two patients underwent liver resection, 28 liver transplantation, 31 transarterial chemoembolization and 14 percutaneous ethanol injection. One hundred and thirty-six patients received no treatment. The Okuda and the Child-Pugh classification predicted a significant decrease of median survival time, whereas the UICC classification was less powerful.
CONCLUSIONS: HCC occurred only in patients with liver cirrhosis. Survival time correlated with therapy (or no therapy) and with the Child-Pugh Score. In European patients the Okuda classification is superior to the UICC classification and should be compared to novel classification systems.

Entities:  

Mesh:

Year:  2002        PMID: 11906615     DOI: 10.1046/j.0106-9543.2001.01571.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  10 in total

1.  The possible role of Sirtuins and microRNAs in hepatocellular carcinoma therapy.

Authors:  Hedyieh Karbasforooshan; A Wallace Hayes; Nooshin Mohammadzadeh; Mohammad Reza Zirak; Gholamreza Karimi
Journal:  Cell Cycle       Date:  2020-11-09       Impact factor: 4.534

2.  Successful embolization of hepatocelluar carcinoma with yttrium-90 glass microspheres prior to liver transplantation.

Authors:  Dean Y Kim; David S Kwon; Riad Salem; Chan K Ma; Marwan S Abouljoud
Journal:  J Gastrointest Surg       Date:  2006-03       Impact factor: 3.452

3.  MiR-1179 represses cell proliferation, migration and invasion of hepatocellular carcinoma through suppression of NUAK2.

Authors:  Dejun Wang; Xue Song; Nan Zhang; Yesong Guo
Journal:  Am J Transl Res       Date:  2022-01-15       Impact factor: 4.060

4.  MicroRNA-29c restores cisplatin sensitivity in liver cancer through direct inhibition of sirtuin 1 expression.

Authors:  Wei Zhang; Peng Luo
Journal:  Oncol Lett       Date:  2018-05-24       Impact factor: 2.967

5.  Measuring hepatic functional reserve using low temporal resolution Gd-EOB-DTPA dynamic contrast-enhanced MRI: a preliminary study comparing galactosyl human serum albumin scintigraphy with indocyanine green retention.

Authors:  Kazuhiro Saito; Joseph Ledsam; Steven Sourbron; Tsuyoshi Hashimoto; Yoichi Araki; Soichi Akata; Koichi Tokuuye
Journal:  Eur Radiol       Date:  2013-08-15       Impact factor: 5.315

6.  Liver transplantation for hepatocellular carcinoma: a single European centre experience.

Authors:  Süleyman Yedibela; Thomas Förtsch; Werner Hohenberger; Thomas Meyer
Journal:  Langenbecks Arch Surg       Date:  2004-02-19       Impact factor: 3.445

7.  Survival rate in patients with hepatocellular carcinoma: a retrospective analysis of 389 patients.

Authors:  T F Greten; F Papendorf; J S Bleck; T Kirchhoff; T Wohlberedt; S Kubicka; J Klempnauer; M Galanski; M P Manns
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

Review 8.  Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: A systematic review and meta-analysis.

Authors:  Xingshun Qi; Diya Wang; Chunping Su; Hongyu Li; Xiaozhong Guo
Journal:  Oncotarget       Date:  2015-07-30

9.  HDAC inhibition activates the apoptosome via Apaf1 upregulation in hepatocellular carcinoma.

Authors:  Reena Buurman; Maria Sandbothe; Brigitte Schlegelberger; Britta Skawran
Journal:  Eur J Med Res       Date:  2016-06-24       Impact factor: 2.175

10.  Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein.

Authors:  Long-Kun Wang; Xi-Na Xie; Xu-Hong Song; Ting Su; Xiao-Lan Chang; Man Xu; Bin Liang; Dong-Yang Huang
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.